Pheburane 483 mg (Sodium Phenylbutyrate GRANULES) 483 MG

PHEBURANE 483 MG granules contain sodium phenylbutyrate, used for managing metabolic conditions. This oral medication helps in reducing ammonia levels in the body.

Strength

483 MG

Pack Size

174G

Manufacturer / TM Owner

MEDUNIK CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PHEBURANE 483 MG granules are primarily used to manage certain metabolic disorders. Sodium phenylbutyrate, the active ingredient, is often prescribed to help reduce ammonia levels in the body. This medication is typically used as part of a broader treatment plan for conditions that affect the body's ability to process proteins.

Side Effects

Common effects of PHEBURANE 483 MG granules may include gastrointestinal discomfort, such as nausea or vomiting. Some users might also experience changes in appetite or body odor. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

PHEBURANE 483 MG granules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Store the granules in a cool, dry place away from direct sunlight and keep them out of reach of children.

Avoid Interactions

PHEBURANE 483 MG granules may interact with certain medications, including those that affect liver function or metabolism. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

PHEBURANE 483 MG granules are used to manage certain metabolic disorders by reducing ammonia levels in the body.

PHEBURANE 483 MG granules are taken orally, typically mixed with food or liquids. Follow the specific instructions provided by your healthcare professional.

Common side effects may include gastrointestinal discomfort, nausea, vomiting, changes in appetite, and body odor.

PHEBURANE 483 MG may interact with certain medications. Consult your healthcare provider before combining it with other drugs.

Store PHEBURANE 483 MG granules in a cool, dry place away from direct sunlight and keep them out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.